Literature DB >> 13678429

Synergistic transcriptional activation of indoleamine dioxygenase by IFN-gamma and tumor necrosis factor-alpha.

Cory M Robinson1, Kari Ann Shirey, Joseph M Carlin.   

Abstract

Interferon-gamma (IFN-gamma)-induced indoleamine 2,3-dioxygenase (IDO) activity inhibits the growth of susceptible intracellular pathogens by catalyzing the oxidative cleavage of the indole ring of L-tryptophan and depleting pools of the essential amino acid. Tumor necrosis factor-alpha (TNF-alpha) synergistically enhances the IDO activity induced by IFN-gamma at the level of transcription in human epithelial cells. The purpose of this study was to characterize the molecular mechanisms responsible for synergistic gene expression in response to IFN-gamma and TNF-alpha. It was found that IFN-gamma-induced mechanisms, such as the binding of Stat1 to gamma activation sequences (GAS) and IFN regulatory factor-1 (IRF-1) to IFN-stimulated response elements (ISREs), are more highly activated following treatment with IFN and TNF-alpha. This enhanced signal transduction may be due to the increase in IFN-gamma receptor (IFNGR) expression following combined cytokine stimulation and is a likely contributor to the synergy. Additionally, the contribution of a third previously uncharacterized GAS element that forms a complex with Stat1 was investigated using a plasmid reporter system that controls for copy number. When the GAS-3 sequence was included in the regulatory region, gene expression was significantly increased relative to a region containing the mutated GAS-3. This suggests that GAS-3 is transcriptionally active and contributes to IFN-gamma-induced regulation of the IDO gene.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13678429      PMCID: PMC1488822          DOI: 10.1089/107999003322277829

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  20 in total

Review 1.  A road map for those who don't know JAK-STAT.

Authors:  David S Aaronson; Curt M Horvath
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

2.  Inhibition of growth of Chlamydia trachomatis by human gamma interferon.

Authors:  Y Shemer; I Sarov
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

3.  Characterization of an indoleamine 2,3-dioxygenase induced by gamma-interferon in cultured human fibroblasts.

Authors:  E R Pfefferkorn; S Rebhun; M Eckel
Journal:  J Interferon Res       Date:  1986-06

4.  Beta interferon inhibits Toxoplasma gondii growth in human monocyte-derived macrophages.

Authors:  J L Schmitz; J M Carlin; E C Borden; G I Byrne
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

5.  Tumor necrosis factor-alpha and lipopolysaccharide enhance interferon-induced antichlamydial indoleamine dioxygenase activity independently.

Authors:  A R Currier; M H Ziegler; M M Riley; T A Babcock; V P Telbis; J M Carlin
Journal:  J Interferon Cytokine Res       Date:  2000-04       Impact factor: 2.607

6.  Indoleamine 2,3-dioxygenase. Purification and some properties.

Authors:  T Shimizu; S Nomiyama; F Hirata; O Hayaishi
Journal:  J Biol Chem       Date:  1978-07-10       Impact factor: 5.157

7.  Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells.

Authors:  G I Byrne; L K Lehmann; G J Landry
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

8.  Analysis of transcription factors regulating induction of indoleamine 2,3-dioxygenase by IFN-gamma.

Authors:  M X Du; W D Sotero-Esteva; M W Taylor
Journal:  J Interferon Cytokine Res       Date:  2000-02       Impact factor: 2.607

9.  Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells.

Authors:  T A Babcock; J M Carlin
Journal:  Cytokine       Date:  2000-06       Impact factor: 3.861

10.  Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan.

Authors:  E R Pfefferkorn
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

View more
  50 in total

1.  Non-hematopoietic expression of IDO is integrally required for inflammatory tumor promotion.

Authors:  Alexander J Muller; James B DuHadaway; Mee Young Chang; Arivudinambi Ramalingam; Erika Sutanto-Ward; Janette Boulden; Alejandro P Soler; Laura Mandik-Nayak; Susan K Gilmour; George C Prendergast
Journal:  Cancer Immunol Immunother       Date:  2010-07-17       Impact factor: 6.968

Review 2.  Amino acid catabolism: a pivotal regulator of innate and adaptive immunity.

Authors:  Tracy L McGaha; Lei Huang; Henrique Lemos; Richard Metz; Mario Mautino; George C Prendergast; Andrew L Mellor
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

3.  Haemophilus ducreyi lipooligosaccharides induce expression of the immunosuppressive enzyme indoleamine 2,3-dioxygenase via type I interferons and tumor necrosis factor alpha in human dendritic cells.

Authors:  Wei Li; Barry P Katz; Stanley M Spinola
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

Review 4.  Human IRGM gene "to be or not to be".

Authors:  Cemaletin Bekpen; Ramnik J Xavier; Evan E Eichler
Journal:  Semin Immunopathol       Date:  2010-08-25       Impact factor: 9.623

5.  Vascular expression, activity and function of indoleamine 2,3-dioxygenase-1 following cerebral ischaemia-reperfusion in mice.

Authors:  Katherine A Jackman; Vanessa H Brait; Yutang Wang; Ghassan J Maghzal; Helen J Ball; Gavin McKenzie; T Michael De Silva; Roland Stocker; Christopher G Sobey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-02-27       Impact factor: 3.000

6.  Elevated interleukin-27 levels in human neonatal macrophages regulate indoleamine dioxygenase in a STAT-1 and STAT-3-dependent manner.

Authors:  Joo-Yong Jung; Madeline Gleave Parson; Jennifer D Kraft; Logan Lyda; Brianna Kobe; Celestia Davis; Jembber Robinson; Maria Marjorette O Peña; Cory M Robinson
Journal:  Immunology       Date:  2016-09       Impact factor: 7.397

7.  Induction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behavior.

Authors:  Jason C O'Connor; Marcus A Lawson; Caroline André; Eileen M Briley; Sandra S Szegedi; Jacques Lestage; Nathalie Castanon; Miles Herkenham; Robert Dantzer; Keith W Kelley
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  B Cell-Intrinsic IDO1 Regulates Humoral Immunity to T Cell-Independent Antigens.

Authors:  Rahul Shinde; Michiko Shimoda; Kapil Chaudhary; Haiyun Liu; Eslam Mohamed; Jillian Bradley; Sridhar Kandala; Xia Li; Kebin Liu; Tracy L McGaha
Journal:  J Immunol       Date:  2015-07-27       Impact factor: 5.422

9.  Apoptotic cells induce dendritic cell-mediated suppression via interferon-gamma-induced IDO.

Authors:  Charlotte A Williams; Rachel A Harry; Julie D McLeod
Journal:  Immunology       Date:  2007-12-07       Impact factor: 7.397

10.  CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression.

Authors:  C L Raison; R Dantzer; K W Kelley; M A Lawson; B J Woolwine; G Vogt; J R Spivey; K Saito; A H Miller
Journal:  Mol Psychiatry       Date:  2009-11-17       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.